5. Industry Overview
5.1 Market Drivers
5.1.1 Growing Focus on Developing of miRNA-based Diagnostic Biomarkers
5.1.2 Technological Advancements
5.1.3 Rise in miRNA-based Researches
5.1.4 Increasing Prevalence of Chronic Diseases
5.1.5 Rising Investments in miRNA Market
5.2 Market Opportunities
5.2.1 Increasing miRNA-based Research in Cardiovascular Biology and Disease
5.2.2 Therapeutics Application Offers Significant Growth Opportunity
5.3 Market Challenges
5.3.1 High Cost of developing miRNA-based Tools
5.3.2 Technological Challenges in Developing miRNA-based Therapeutics
5.4 Market Trends
5.4.1 Increasing Strategic Alliances in the Market
5.4.2 Next Generation Sequencing: Gaining Momentum
6. Global miRNA Market Outlook to 2020
6.1 miRNA Tools and Services Market
7. Global miRNA Market by Applications
7.1 Research
7.2 Diagnostics
7.3 Drug Development
8. Global miRNA Market by End User
8.1 Research Labs and Institutes
8.2 Biotechnology Industry
8.3 Hospitals and Diagnostic Centers
9. Global miRNA Market by Geography
9.1 The Americas
9.2 Europe
9.3 Asia Pacific (APAC)
10. Global miRNA Market, by Disease
10.1 Introduction
10.2 Cancer
10.3 Neurological Diseases
10.4 Cardiovascular Diseases
10.5 Hepatic Diseases
10.6 Other Diseases
11. Portfolio of miRNA Pathway Drugs Candidates
12. Key Players
12.1 QIAGEN
12.2 Sigma-Aldrich Corporation (A Subsidiary of Merck KGaA)
12.3 Thermo Fisher Scientific, Inc.
12.4 Agilent Technologies Inc.
12.5 Affymetrix
12.6 Integrated DNA Technologies
12.7 Exiqon
12.8 Mirus Bio LLC
12.9 Wako Pure Chemical Industries
12.10 Rosetta Genomics Ltd.